Clinical Trials
Before vaccines are used, they are tested for clinical trials in thousands and are strictly monitored for safety. The results of these clinical trials form the foundation for on-going testing and monitoring that lasts for the lifetime of each vaccine. Vaccine sponsors tests for its safety through further clinical trials and vaccine adverse events and detailed surveillance of disease. New vaccine is manufactured then it undergoes safety testing until it is licensed for further use
- Improving both the quality and quantity of the delivery of vaccination services
- Minimizing financial burdens for needy persons
- Increasing community awareness, participation, education, and partnership
- Improving disease monitoring and vaccination coverage
- Developing new or improved vaccines and improving the use of vaccines
Related Conference of Clinical Trials
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Clinical Trials Conference Speakers
Recommended Sessions
- Immunopathogenesis
- Vaccines for Therapeutic and Treatment
- Animal and Plant Derived Vaccines
- Clinical Immunology
- Clinical Trials
- Diagnostic Immunology
- Diseases and Vaccines
- Geriatric Immunizations
- Immunoinformatics
- Immunology
- Immunotoxicology
- Stem cell Immunology
- Vaccine Safety
- Vaccine Technology
- Vaccines against Drugs
- Vaccines and Immunization
- Vaccinology
- Veterinary Vaccines
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)